insights_auto
Why is PLUR down 3.15%?
Dive Deeperchevron_right
PLUR:NASDAQ
Pluri Inc
$1.23
arrow_downward
-3.15%(-0.040) 1D
Nov 4, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLUR...
Open
$1.27
High
$1.27
Low
$1.20
Mkt. cap
15.18M
Avg. vol.
48.76K
Volume
16.86K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.64
Shares outstanding
12.61M
No. of employees
103
Open
$1.27
High
$1.27
Low
$1.20
Mkt. cap
15.18M
Avg. vol.
48.76K
Volume
16.86K
52-wk high
$4.86
52-wk low
$0.85
EPS
-$2.44
Beta
0.64
Shares outstanding
12.61M
No. of employees
103
News stories
From web sources and news partners
MarketWatch
·
49 minutes ago
Dow scores its best day in 18 months in a broad relief rally after Democrats sweep to power in Congress
FinancialContent
·
21 minutes ago
Corpay’s (NYSE:CPAY) Q3 2026 sales beat estimates
shattered.io
·
16 minutes ago
S&P Earnings Jump 30.2% as Big Tech Cash Flow Sinks [2026]
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees103
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorBiotechnology
Industry-
Websitepluri-biotech.com